Treatment with biologic or targeted synthetic disease-modifying antirheumatic drugs failed to mitigate bone mineral density ...

A study of 98,000 veterans shows that combining GLP-1 RA therapy with healthy lifestyle habits significantly lowers MACE risk in T2D.

India is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 ...

Menopause and Rheumatoid Arthritis often overlap, worsening joint pain, stiffness, and fatigue. Falling estrogen levels can trigger inflammation and RA flare-ups, while symptoms are often mistaken for ...

Among patients with AD, GLP-1 RAs reduced the risk for various MACE outcomes, including heart failure, cerebrovascular disease, and more.

AnaptysBio is splitting into a high-margin royalty company and a pipeline-focused biopharma, each with distinct valuation ...

Rheumatoid arthritis (RA) is a chronic autoimmune disorder whose hallmark symptom is inflammation in the joints resulting in swelling, pain, and stiffness. But RA, particularly if left untreated or ...

An individual patient data meta-analysis of two randomized trials involving treatment-naive patients with early rheumatoid arthritis (RA) found that a hand-dominant joint involvement pattern was ...

Pancreatic enzyme replacement therapy (PERT) — commonly used to reverse the insufficient secretion of pancreatic enzymes, or pancreatic exocrine insufficiency (PEI) — showed benefit in the treatment ...

Investigators studied GLP-1 receptor agonist use and renal and inflammatory outcomes among patients with systemic lupus erythematosus and type 2 diabetes mellitus.

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced that the New ...

Among people newly diagnosed with rheumatoid arthritis, important questions arise about causes, symptoms, and treatment ...